First Participant Randomized in AskBio European Phase 2 Gene Therapy Trial for Congestive Heart Failure
AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...
Asklepios BioPharmaceutical, Inc. (AskBio): First Participant Randomized in AskBio European Phase 2 Gene Therapy Trial for Congestive Heart Failure
AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) ...
TAG24 NEWS on MSN9m
Am I just getting older? How to recognize dementia warning signs
When dementia is diagnosed early on, there are more treatment and management options.Dr. Sudha Seshadri — the founding director of the Alzheimer’s and neurodegenerative diseases institute at UT Health ...